Literature DB >> 6974965

Pulmonary candidiasis in infants: clinical, radiologic, and pathologic features.

E G Kassner, S L Kauffman, J J Yoon, M Semiglia, P J Kozinn, P L Goldberg.   

Abstract

Although systemic candidiasis is common in hospitalized patients, invasive pulmonary candidiasis is rare and generally considered of secondary importance when found at autopsy. Autopsy records for a 12 year period were reviewed and 15 infants were found in whom systemic candidiasis was considered the primary or a major contributory cause of death. Significant pulmonary involvement was found in 14. There were three characteristic histologic patterns of pulmonary candidiasis: (1) embolic (arterial-invasive) (seven cases); (2) disseminated (capillary-invasive) (four cases); and (3) bronchopulmonary (air space-invasive) (three cases, including one congenital infection). An indwelling vascular catheter or infected cutdown wound was the portal of entry in every case of the embolic form of pulmonary candidiasis. Systemic and pulmonary Candida infections were rarely diagnosed during life. The typical radiographic appearance was progressive air space consolidation, although two infants with the embolic form of pulmonary candidiasis had focal cavitation. In general, there was poor correlation between the radiologic and pathologic findings, and pathologic findings other than pulmonary candidiasis undoubtedly accounted for many of the radiologic abnormalities observed. There were no radiologic findings that could be used to differentiate the three histologic forms of lung involvement in these patients. Small lung nodules, the earliest histologic lesion of pulmonary candidiasis, were not seen in any patient owing to the presence of other lung disease and suboptimal radiographic technique.

Entities:  

Mesh:

Year:  1981        PMID: 6974965     DOI: 10.2214/ajr.137.4.707

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Antifungal treatment strategy in leukemia patients.

Authors:  T Büchner; N Roos
Journal:  Ann Hematol       Date:  1992-10       Impact factor: 3.673

2.  Molecular epidemiology of Candida albicans colonization and fungemia in very low birthweight infants.

Authors:  J L Robinson; A I Hartstein; R U Meuser; V H Morthland; M E Dragoon; W M Wenman
Journal:  Can J Infect Dis       Date:  1993-11

3.  Pulmonary fungal infections in patients with hematological malignancies--diagnostic approaches.

Authors:  M von Eiff; M Zühlsdorf; N Roos; M Hesse; R Schulten; J van de Loo
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

Review 4.  Systemic fungal infections in neonates.

Authors:  P C Ng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-09       Impact factor: 5.747

5.  Candida strains from neonates in a special care baby unit.

Authors:  A M Sharp; F C Odds; E G Evans
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

6.  Pulmonary vascular candidiasis and use of central venous catheters in neonates.

Authors:  W F Knox; V N Hooton; A J Barson
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

7.  Case report of invasive, disseminated candidiasis with peripheral nodular cavitary lesions in the lung.

Authors:  Hafiza Arshad; Silvia Garcia; Misbahuddin Khaja
Journal:  Respir Med Case Rep       Date:  2016-11-10

8.  A consensus document for the clinical management of invasive fungal diseases in pediatric patients with hematologic cancer and/or undergoing hematopoietic stem cell transplantation in Brazilian medical centers.

Authors:  Fabianne Carlesse; Liane Esteves Daudt; Adriana Seber; Álvaro Pimenta Dutra; Analy Salles de Azevedo Melo; Belinda Simões; Carla Renata Donato Macedo; Carmem Bonfim; Eliana Benites; Lauro Gregianin; Marjorie Vieira Batista; Marcelo Abramczyk; Vivian Tostes; Henrique Manoel Lederman; Maria Lúcia de Martino Lee; Sandra Loggetto; Cláudio Galvão de Castro Junior; Arnaldo Lopes Colombo
Journal:  Braz J Infect Dis       Date:  2019-11-16       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.